Menin inhibition with revumenib for KMT2A -rearranged relapsed or refractory acute leukemia (AUGMENT-101) Journal Article
| Authors: | Issa, G. C.; Aldoss, I.; Thirman, M. J.; DiPersio, J.; Arellano, M.; Blachly, J. S.; Mannis, G. N.; Perl, A.; Dickens, D. S.; McMahon, C. M.; Traer, E.; Zwaan, C. M.; Grove, C. S.; Stone, R.; Shami, P. J.; Mantzaris, I.; Greenwood, M.; Shukla, N.; Cuglievan, B.; Kovacsovics, T.; Gu. Y.; Greenwood, M.; Shukla, N.; Cuglievan, B.; McNeer, N.; Stein, E. M. |
| Article Title: | Menin inhibition with revumenib for KMT2A -rearranged relapsed or refractory acute leukemia (AUGMENT-101) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 1 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-01-01 |
| Start Page: | 75 |
| End Page: | 84 |
| DOI: | 10.1200/jco.24.00826 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl plus with full text |
| PMCID: | PMC11687943 |
| PUBMED: | 39121437 |
| DOI/URL: | |
| Notes: | The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PubMed record. Source: CINAHL Plus with Full Text |
